Idogen AB (publ)

OM:IDOGEN Lagerbericht

Marktkapitalisierung: SEK 12.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Idogen Management

Management Kriterienprüfungen 1/4

Idogen's CEO is Christina Herder, appointed in Sep 2022, they has a tenure of less than a year. Their total yearly compensation is SEK454.00K , comprised of 66.1% salary and 33.9% bonuses, including company stock and options. They directly owns 0.06% of the company’s shares, worth SEK7.56K. The average tenure of the management team and the board of directors is 1.5 years and 2.7 years respectively.

Wichtige Informationen

Christina Herder

Geschäftsführender

SEK 454.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts66.1%
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführers0.06%
Durchschnittliche Amtszeit des Managements1.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.7yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Christina Herder im Vergleich zu den Einnahmen von Idogen verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2023n/an/a

-SEK 44m

Dec 31 2022SEK 454kSEK 300k

-SEK 48m

Sep 30 2022n/an/a

-SEK 50m

Jun 30 2022n/an/a

-SEK 41m

Mar 31 2022n/an/a

-SEK 39m

Dec 31 2021SEK 150kn/a

-SEK 39m

Sep 30 2021n/an/a

-SEK 33m

Jun 30 2021n/an/a

-SEK 33m

Mar 31 2021n/an/a

-SEK 31m

Dec 31 2020SEK 150kn/a

-SEK 27m

Vergütung im Vergleich zum Markt: Christina's total compensation ($USD42.19K) is below average for companies of similar size in the Swedish market ($USD231.64K).

Entschädigung vs. Einkommen: Christina's compensation has increased whilst the company is unprofitable.

Geschäftsführer

Christina Herder (62 yo)

less than a year

Amtszeit

SEK 454,000

Vergütung

Dr. Christina Herder, Ph D., served as Independent Director for Ziccum AB (publ) since April 28, 2022 until May 2023. She is Director at Beactica AB since 2021.She is a Director at Elicera Therapeutics AB...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Christina Herder
Acting CEO & Directorless than a yearSEK 454.00k0.060%
SEK 7.6k
Leif Salford
Founder & Chairman of the Scientific Advisory Boardno dataSEK 150.00k0.17%
SEK 22.0k
Ingvar Karlsson
Chief Financial Officer7.2yrskeine Daten0.33%
SEK 42.1k
Dennis Henriksen
Chief Technology Officer9.5yrsSEK 120.74k0.012%
SEK 1.5k
Hanjing Xie
Chief Medical Officer1.5yrskeine Datenkeine Daten
Rory Graham
Chief Regulatory Officer1.3yrskeine Datenkeine Daten

1.5yrs

Durchschnittliche Betriebszugehörigkeit

62yo

Durchschnittliches Alter

Erfahrenes Management: IDOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Christina Herder
Acting CEO & Director6.2yrsSEK 454.00k0.060%
SEK 7.6k
Leif Salford
Founder & Chairman of the Scientific Advisory Board7.8yrsSEK 150.00k0.17%
SEK 22.0k
Agneta Edberg
Independent Chairman of the Board7.3yrsSEK 407.00k0.15%
SEK 18.9k
Rolf Ljung
Member of Scientific Advisory Board7.8yrskeine Datenkeine Daten
Jolanda de Vries
Member of Scientific Advisory Board2.3yrskeine Datenkeine Daten
Sharon Longhurst
Independent Director3.2yrsSEK 150.00k0.089%
SEK 11.1k
Michaela Sharpe
Member of Scientific Advisory Board2.3yrskeine Datenkeine Daten
Bo-Goran Ericzon
Member of Scientific Advisory Board2.3yrskeine Datenkeine Daten
Michael Uhlin
Member of Scientific Advisory Boardless than a yearkeine Datenkeine Daten
Mats Bemark
Member of Scientific Advisory Boardless than a yearkeine Datenkeine Daten

2.7yrs

Durchschnittliche Betriebszugehörigkeit

64.5yo

Durchschnittliches Alter

Erfahrener Vorstand: IDOGEN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.